Skip to main content
. 2016 Sep 14;22(34):7676–7691. doi: 10.3748/wjg.v22.i34.7676

Table 1.

Biomarkers of tolerance in liver transplantation

Biomarker Description Study before or during IS withdrawal Ref.
Dendritic cells
pCD/mCD ratio Tolerant patients have elevated pDC/mDC ratio. No differences between tolerant patients vs healthy controls No [134,150]
mDCs/pCD ratio Elevated mDC/pCD associated with late rejection No [151]
PD-L1/CD86 ratio Elevated PD-L1/CD86 expression on DCs in tolerant patients No [152]
DC HLA-G expression Elevated on mDC No [153]
T cells
Regulatory T cells Increase of peripheral CD4+CD25high cells and RNA FoxP3 over time during weaning Yes [40,43,44,133]
Increase in T regs in liver biopsy of tolerant patients
Natural killer Increase in Tolerant patients Yes [154]
Soluble factors
Serum HLA-G Normal or elevated serum HLA-G levels associated to normal liver No [155-157]
Anti-donor antibodies Absent in tolerant patients No [150]
Cell proliferation
Phytohemagglutinin SI SI < 20 and > 10 yr since LT 100% tolerance Yes [158]
Genetic profile
Cytokine gene polymorphism Low TNF-alpha and high/intermediate IL-10 production in OT No [159]
Gene transcripts Enriched from NK, CD4+CD25+ FoxP3+, γδTCR+ and δ1TCR+ No [42,43,160]
Genes related to iron homeostasis in liver graft Enriched in tolerant patients (CDHR2, MIF, PEBP1, SOCS1, TRF) Yes [140]

DC: Dendritic cell; mDC: Monocytoid dendritic cell; LT: Liver transplantation; pDC: plasmacytoid dendritic cell; SI: Stimulation index.